BiotechTube
Home/Immunic/Dr. Andreas Muehler
DA

Dr. Andreas Muehler

Chief Medical Officer

Immunic

Therapeutic Areas

Multiple SclerosisInflammatory Bowel DiseaseAutoimmune Diseases

Immunic Pipeline

DrugIndicationPhase
Vidofludimus calcium (IMU-838)Relapsing-Remitting Multiple Sclerosis (RRMS)Phase 3
IMU-856Celiac Disease / GI Barrier FunctionPhase 1b
IMU-935 / IMU-856Psoriasis / Inflammatory DiseasesPreclinical / Phase 1

Leadership Team at Immunic

DD
Dr. Daniel Vitt
President, CEO, and Chairman of the Management Board
DD
Dr. Duane Nash
Chairman of the Supervisory Board
DH
Dr. H. Daniel Perez
Board Member
View full Immunic profile